Filter

Refine by date

—

Refine by collections

  • Print
  • Save

Search Results

You are looking at 1 - 10 of 86 items for :

  • Papillary thyroid microcarcinoma x
Clear All
Min Ji Jeon Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

Search for other papers by Min Ji Jeon in
Google Scholar
PubMed Close
,
Won Gu Kim Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

Search for other papers by Won Gu Kim in
Google Scholar
PubMed Close
,
Ki-Wook Chung Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

Search for other papers by Ki-Wook Chung in
Google Scholar
PubMed Close
,
Jung Hwan Baek Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

Search for other papers by Jung Hwan Baek in
Google Scholar
PubMed Close
,
Won Bae Kim Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

Search for other papers by Won Bae Kim in
Google Scholar
PubMed Close
, and
Young Kee Shong Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

Search for other papers by Young Kee Shong in
Google Scholar
PubMed Close

carcinomas (PTCs) including papillary thyroid microcarcinomas (PTMCs) [ 1 , 2 ]. For the last several decades, we did not have sufficient knowledge of the biological behavior of PTMCs, and were surprised to find that many of these PTMCs have similar

Article Type:
Review Article
DOI:
https://doi.org/10.1159/000503064
Volume/Issue:
Volume 8: Issue 6
Free access
F. Cecoli Endocrinology, Nuclear Medicine and Autoimmunity Laboratory, Department of Internal Medicine, and Department of Experimental Medicine, Genoa University, and IRCCS Azienda Ospedaliera Universitaria San Martino - IST Genoa

Search for other papers by F. Cecoli in
Google Scholar
PubMed Close
,
E.M. Ceresola Endocrinology, Nuclear Medicine and Autoimmunity Laboratory, Department of Internal Medicine, and Department of Experimental Medicine, Genoa University, and IRCCS Azienda Ospedaliera Universitaria San Martino - IST Genoa

Search for other papers by E.M. Ceresola in
Google Scholar
PubMed Close
,
V. Altrinetti Endocrinology and Nuclear Medicine, Galliera Hospital, Genoa

Search for other papers by V. Altrinetti in
Google Scholar
PubMed Close
,
M. Cabria Endocrinology and Nuclear Medicine, Galliera Hospital, Genoa

Search for other papers by M. Cabria in
Google Scholar
PubMed Close
,
M. Cappagli Endocrine Unit, Sant'Andrea Hospital, La Spezia

Search for other papers by M. Cappagli in
Google Scholar
PubMed Close
,
A. Montepagani Endocrine Unit, Sant'Andrea Hospital, La Spezia

Search for other papers by A. Montepagani in
Google Scholar
PubMed Close
,
C.M. Cuttica Endocrinology and Nuclear Medicine, Galliera Hospital, Genoa

Search for other papers by C.M. Cuttica in
Google Scholar
PubMed Close
,
U. Filippi Evangelico Internazionale Hospital, Genoa

Search for other papers by U. Filippi in
Google Scholar
PubMed Close
,
D. Saverino Endocrinology, Nuclear Medicine and Autoimmunity Laboratory, Department of Internal Medicine, and Department of Experimental Medicine, Genoa University, and IRCCS Azienda Ospedaliera Universitaria San Martino - IST Genoa

Search for other papers by D. Saverino in
Google Scholar
PubMed Close
,
M. Raffa Endocrine-Metabolic Center, ASL 1, Imperia, Italy

Search for other papers by M. Raffa in
Google Scholar
PubMed Close
,
M. Caputo Endocrinology, Nuclear Medicine and Autoimmunity Laboratory, Department of Internal Medicine, and Department of Experimental Medicine, Genoa University, and IRCCS Azienda Ospedaliera Universitaria San Martino - IST Genoa

Search for other papers by M. Caputo in
Google Scholar
PubMed Close
,
F. Minuto Endocrinology, Nuclear Medicine and Autoimmunity Laboratory, Department of Internal Medicine, and Department of Experimental Medicine, Genoa University, and IRCCS Azienda Ospedaliera Universitaria San Martino - IST Genoa

Search for other papers by F. Minuto in
Google Scholar
PubMed Close
,
M. Giusti Endocrinology, Nuclear Medicine and Autoimmunity Laboratory, Department of Internal Medicine, and Department of Experimental Medicine, Genoa University, and IRCCS Azienda Ospedaliera Universitaria San Martino - IST Genoa

Search for other papers by M. Giusti in
Google Scholar
PubMed Close
, and
M. Bagnasco Endocrinology, Nuclear Medicine and Autoimmunity Laboratory, Department of Internal Medicine, and Department of Experimental Medicine, Genoa University, and IRCCS Azienda Ospedaliera Universitaria San Martino - IST Genoa

Search for other papers by M. Bagnasco in
Google Scholar
PubMed Close

Introduction The incidence of papillary thyroid cancer (PTC) has almost doubled over the last three decades mainly due to the higher incidence of papillary thyroid microcarcinoma (MPTC) [ 1 , 2 ]. In Italy, a remarkably high PTC incidence has

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000446746
Volume/Issue:
Volume 5: Issue 3
Free access
Ho-Ryun Won Department of Otorhinolaryngology-Head and Neck Surgery, Chungnam National University College of Medicine, Daejeon, Republic of Korea
Department of Otorhinolaryngology-Head and Neck Surgery, Chungnam National University Sejong Hospital, Sejong, Republic of Korea

Search for other papers by Ho-Ryun Won in
Google Scholar
PubMed Close
,
Min Gyu Kim Department of Otorhinolaryngology-Head and Neck Surgery, Chungnam National University College of Medicine, Daejeon, Republic of Korea

Search for other papers by Min Gyu Kim in
Google Scholar
PubMed Close
,
Min Soo Kim Department of Otorhinolaryngology-Head and Neck Surgery, Chungnam National University College of Medicine, Daejeon, Republic of Korea

Search for other papers by Min Soo Kim in
Google Scholar
PubMed Close
,
Jae Won Chang Department of Otorhinolaryngology-Head and Neck Surgery, Chungnam National University College of Medicine, Daejeon, Republic of Korea
Department of Otolaryngology-Head and Neck Surgery, Chungnam National University Hospital, Daejeon, Republic of Korea

Search for other papers by Jae Won Chang in
Google Scholar
PubMed Close
, and
Bon Seok Koo Department of Otorhinolaryngology-Head and Neck Surgery, Chungnam National University College of Medicine, Daejeon, Republic of Korea
Department of Otolaryngology-Head and Neck Surgery, Chungnam National University Hospital, Daejeon, Republic of Korea

Search for other papers by Bon Seok Koo in
Google Scholar
PubMed Close

increase in papillary thyroid microcarcinoma (PTMC), defined as papillary thyroid carcinoma less than 1 cm; accordingly, concerns have been raised regarding overdiagnosis ( 6 , 7 ). Another characteristic of thyroid cancer is indolent progression

Article Type:
Research Article
Collections:
Thyroid cancer - clinical
DOI:
https://doi.org/10.1530/ETJ-23-0195
Volume/Issue:
Volume 12: Issue 6
Open access
Pedro Weslley Souza Rosario Santa Casa de Belo Horizonte, Belo Horizonte, Brazil

Search for other papers by Pedro Weslley Souza Rosario in
Google Scholar
PubMed Close
,
Gabriela Franco Mourão Santa Casa de Belo Horizonte, Belo Horizonte, Brazil

Search for other papers by Gabriela Franco Mourão in
Google Scholar
PubMed Close
,
Pedro Henrique Lopes Oliveira Santa Casa de Belo Horizonte, Belo Horizonte, Brazil

Search for other papers by Pedro Henrique Lopes Oliveira in
Google Scholar
PubMed Close
, and
Tulio Henrique Silva Santa Casa de Belo Horizonte, Belo Horizonte, Brazil

Search for other papers by Tulio Henrique Silva in
Google Scholar
PubMed Close

shows that surgery can detect features associated with a poor prognosis in adults with a preoperative diagnosis of “nonaggressive papillary microcarcinoma restricted to the thyroid,” and thus potential candidates for AS [ 1 - 5 ]. How often this occurs

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000490701
Volume/Issue:
Volume 7: Issue 5
Free access
Maria Rossing Department of Endocrinology, Herlev University Hospital, Herlev
Center of Genomic Medicine, Rigshospitalet, Copenhagen University, Copenhagen, Denmark

Search for other papers by Maria Rossing in
Google Scholar
PubMed Close
,
Birte Nygaard Department of Endocrinology, Herlev University Hospital, Herlev

Search for other papers by Birte Nygaard in
Google Scholar
PubMed Close
,
Finn Cilius Nielsen Center of Genomic Medicine, Rigshospitalet, Copenhagen University, Copenhagen, Denmark

Search for other papers by Finn Cilius Nielsen in
Google Scholar
PubMed Close
, and
Finn Noe Bennedbæk Department of Endocrinology, Herlev University Hospital, Herlev

Search for other papers by Finn Noe Bennedbæk in
Google Scholar
PubMed Close

Frates et al. [ 7 ] the accumulated predicted value of US characteristics and basic clinical features ranged between 3 and 48%. The papillary thyroid microcarcinoma (PTMC) is a papillary thyroid carcinoma with a size of ≤1 cm. The overall incidence of

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000338921
Volume/Issue:
Volume 1: Issue 2
Open access
Pedro Weslley Souza Rosario Santa Casa de Belo Horizonte, Belo Horizonte, Brazil

Search for other papers by Pedro Weslley Souza Rosario in
Google Scholar
PubMed Close

Dear Editor, Recently, Russ et al. [ 1 ] endorsed active surveillance for low-risk papillary microcarcinoma of the thyroid (PMT). It is also reasonable to imagine that, if immediate treatment is not necessary, fine-needle aspiration (FNA) of

Article Type:
Letter
DOI:
https://doi.org/10.1159/000486671
Volume/Issue:
Volume 7: Issue 3
Free access
Haggi Mazeh Department of Surgery, Jerusalem, Israel

Search for other papers by Haggi Mazeh in
Google Scholar
PubMed Close
,
Amir Orlev Department of Surgery, Jerusalem, Israel

Search for other papers by Amir Orlev in
Google Scholar
PubMed Close
,
Ido Mizrahi Department of Surgery, Jerusalem, Israel

Search for other papers by Ido Mizrahi in
Google Scholar
PubMed Close
,
David J. Gross Endocrinology and Metabolism Service Hadassah-Hebrew University Medical Center, Jerusalem, Israel

Search for other papers by David J. Gross in
Google Scholar
PubMed Close
, and
Herbert R. Freund Department of Surgery, Jerusalem, Israel

Search for other papers by Herbert R. Freund in
Google Scholar
PubMed Close

case for all micromedullary tumors. In one study, calcitonin levels were only elevated in tumors larger than 0.5 cm [ 14 ]. In contrast to MTC, the incidence of incidental papillary thyroid microcarcinoma is common, well documented and investigated

Article Type:
Case Report
DOI:
https://doi.org/10.1159/000368750
Volume/Issue:
Volume 4: Issue 1
Free access
Dillwyn Williams Department of Public Health, University of Cambridge, Cambridge, UK

Search for other papers by Dillwyn Williams in
Google Scholar
PubMed Close

to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid 2014;24:27-34. 10.1089/thy.2013.0367 24001104 40 So YK, Son YI, Hong SD: Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of

Article Type:
Review Article
DOI:
https://doi.org/10.1159/000437263
Volume/Issue:
Volume 4: Issue 3
Free access
Amanda La Greca Endocrinology Service, Department of Medicine, New York, N.Y., USA

Search for other papers by Amanda La Greca in
Google Scholar
PubMed Close
,
Bin Xu Department of Pathology, Memorial Sloan-Kettering Cancer Center and Weill-Cornell College of Medicine, New York, N.Y., USA

Search for other papers by Bin Xu in
Google Scholar
PubMed Close
,
Ronald Ghossein Department of Pathology, Memorial Sloan-Kettering Cancer Center and Weill-Cornell College of Medicine, New York, N.Y., USA

Search for other papers by Ronald Ghossein in
Google Scholar
PubMed Close
,
R. Michael Tuttle Endocrinology Service, Department of Medicine, New York, N.Y., USA

Search for other papers by R. Michael Tuttle in
Google Scholar
PubMed Close
, and
Mona M. Sabra Endocrinology Service, Department of Medicine, New York, N.Y., USA

Search for other papers by Mona M. Sabra in
Google Scholar
PubMed Close

[ 1 , 2 , 3 ]. Multifocal papillary thyroid carcinomas (PTC) can be divided into 2 categories depending on the tumor size: multifocal papillary microcarcinoma (all of the lesions sized <1 cm) and multifocal macroscopic papillary thyroid cancer

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000448752
Volume/Issue:
Volume 6: Issue 1
Free access
Marta Nascimento Soares Faculty of Medicine of the University of Porto, Porto, Portugal

Search for other papers by Marta Nascimento Soares in
Google Scholar
PubMed Close
,
Marta Borges-Canha Faculty of Medicine of the University of Porto, Porto, Portugal
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário de São João, Porto, Portugal
Department of Surgery and Physiology, Cardiovascular Research Unit, Faculty of Medicine from the University of Porto, Porto, Portugal

Search for other papers by Marta Borges-Canha in
Google Scholar
PubMed Close
,
Celestino Neves Faculty of Medicine of the University of Porto, Porto, Portugal
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário de São João, Porto, Portugal
Institute for Research Innovation in Health, University of Porto, Porto, Portugal

Search for other papers by Celestino Neves in
Google Scholar
PubMed Close
,
João Sérgio Neves Faculty of Medicine of the University of Porto, Porto, Portugal
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário de São João, Porto, Portugal
Department of Surgery and Physiology, Cardiovascular Research Unit, Faculty of Medicine from the University of Porto, Porto, Portugal

Search for other papers by João Sérgio Neves in
Google Scholar
PubMed Close
, and
Davide Carvalho Faculty of Medicine of the University of Porto, Porto, Portugal
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário de São João, Porto, Portugal
Institute for Research Innovation in Health, University of Porto, Porto, Portugal

Search for other papers by Davide Carvalho in
Google Scholar
PubMed Close

papillary carcinomas, and 1 (5.6%) was NIFTP (non-invasive follicular thyroid neoplasm with papillary-like nuclear features). Of the 10 microcarcinomas, 3 were discovered on preoperatory FNA, 1 discovered by FNA of a cervical lymph node, and 6 were an

Article Type:
Research Article
Collections:
Hyperthyroidism and thyrotoxicosis
DOI:
https://doi.org/10.1530/ETJ-23-0055
Volume/Issue:
Volume 12: Issue 4
Open access